These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32489806)

  • 21. Results of a hypertension and diabetes treatment program in the slums of Nairobi: a retrospective cohort study.
    Werner ME; van de Vijver S; Adhiambo M; Egondi T; Oti SO; Kyobutungi C
    BMC Health Serv Res; 2015 Nov; 15():512. PubMed ID: 26577953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies.
    Zhang YB; Chen C; Pan XF; Guo J; Li Y; Franco OH; Liu G; Pan A
    BMJ; 2021 Apr; 373():n604. PubMed ID: 33853828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study).
    Witberg G; Ayers CR; Turer AT; Lev E; Kornowski R; de Lemos J; Neeland IJ
    Am J Cardiol; 2016 Feb; 117(4):574-579. PubMed ID: 26800774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-year (2002-2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: the ATTICA Study.
    Panagiotakos DB; Georgousopoulou EN; Pitsavos C; Chrysohoou C; Metaxa V; Georgiopoulos GA; Kalogeropoulou K; Tousoulis D; Stefanadis C;
    Int J Cardiol; 2015 Feb; 180():178-84. PubMed ID: 25463360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ignorance of cardiovascular preventive measures is associated with all-cause and cardiovascular mortality in the French general population.
    Séguro F; Taraszkiewicz D; Bongard V; Bérard E; Bouisset F; Ruidavets JB; Ferrières J
    Arch Cardiovasc Dis; 2016; 109(8-9):486-93. PubMed ID: 27342804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Socioeconomic Status as Predictors of Cardiovascular Disease Incidence and Mortality: A 10-Year Follow-Up of a Polish-Population-Based HAPIEE Cohort.
    Kozela M; Polak M; Stepaniak U; Bobak M; Pająk A
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36430130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in non-communicable disease mortality among adult residents in Nairobi's slums, 2003-2011: applying InterVA-4 to verbal autopsy data.
    Oti SO; van de Vijver S; Kyobutungi C
    Glob Health Action; 2014; 7():25533. PubMed ID: 25377336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of socioeconomic factors with cause-specific Mortality and burden of cardiovascular diseases: findings from the vital registration in urban Shanghai, China, during 1974-2015.
    Zhang L; Li Q; Han X; Wang S; Li P; Ding Y; Zhang T; Zhao J; Chen Y; Liu J; Li J; Tan X; Liu W; Zhang R; Cao G
    BMC Public Health; 2020 Aug; 20(1):1291. PubMed ID: 32847504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Joint Associations of Race, Ethnicity, and Socioeconomic Status With Mortality in the Multiethnic Cohort Study.
    Sangaramoorthy M; Shariff-Marco S; Conroy SM; Yang J; Inamdar PP; Wu AH; Haiman CA; Wilkens LR; Gomez SL; Le Marchand L; Cheng I
    JAMA Netw Open; 2022 Apr; 5(4):e226370. PubMed ID: 35404461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and factors associated with health insurance coverage in resource-poor urban settings in Nairobi, Kenya: a cross-sectional study.
    Otieno PO; Wambiya EOA; Mohamed SF; Donfouet HPP; Mutua MK
    BMJ Open; 2019 Dec; 9(12):e031543. PubMed ID: 31843827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incident risk and burden of cardiovascular diseases attributable to long-term NO
    Wang K; Yuan Y; Wang Q; Yang Z; Zhan Y; Wang Y; Wang F; Zhang Y
    Environ Int; 2023 Aug; 178():108060. PubMed ID: 37478679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medications for blood pressure, blood glucose, lipids, and anti-thrombotic medications: relationship with cardiovascular disease and death in adults from 21 high-, middle-, and low-income countries with an elevated body mass index.
    Leong DP; Rangarajan S; Rosengren A; Oguz A; Alhabib KF; Poirier P; Diaz R; Dans AL; Iqbal R; Yusufali AM; Yeates K; Chifamba J; Seron P; Lopez-Lopez J; Bahonar A; Wei L; Bo H; Weida L; Avezum A; Gupta R; Mohan V; Kruger HS; Lakshmi PVM; Yusuf R; Yusuf S
    Eur J Prev Cardiol; 2022 Oct; 29(14):1817-1826. PubMed ID: 35512128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study.
    Lear SA; Hu W; Rangarajan S; Gasevic D; Leong D; Iqbal R; Casanova A; Swaminathan S; Anjana RM; Kumar R; Rosengren A; Wei L; Yang W; Chuangshi W; Huaxing L; Nair S; Diaz R; Swidon H; Gupta R; Mohammadifard N; Lopez-Jaramillo P; Oguz A; Zatonska K; Seron P; Avezum A; Poirier P; Teo K; Yusuf S
    Lancet; 2017 Dec; 390(10113):2643-2654. PubMed ID: 28943267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hypertension and associated cardiovascular risk factors in an urban slum in Nairobi, Kenya: a population-based survey.
    Joshi MD; Ayah R; Njau EK; Wanjiru R; Kayima JK; Njeru EK; Mutai KK
    BMC Public Health; 2014 Nov; 14():1177. PubMed ID: 25407513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the association between low socioeconomic status and cardiovascular disease risk in healthy Greeks, in the years of financial crisis (2002-2012): The ATTICA study.
    Kollia N; Panagiotakos DB; Georgousopoulou E; Chrysohoou C; Tousoulis D; Stefanadis C; Papageorgiou C; Pitsavos C
    Int J Cardiol; 2016 Nov; 223():758-763. PubMed ID: 27573601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose Study.
    Afsharian S; Akbarpour S; Abdi H; Sheikholeslami F; Moeini AS; Khalili D; Momenan AA; Azizi F; Hadaegh F
    Diabetes Metab Res Rev; 2016 Sep; 32(6):596-606. PubMed ID: 26787367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
    Yusuf S; Joseph P; Rangarajan S; Islam S; Mente A; Hystad P; Brauer M; Kutty VR; Gupta R; Wielgosz A; AlHabib KF; Dans A; Lopez-Jaramillo P; Avezum A; Lanas F; Oguz A; Kruger IM; Diaz R; Yusoff K; Mony P; Chifamba J; Yeates K; Kelishadi R; Yusufali A; Khatib R; Rahman O; Zatonska K; Iqbal R; Wei L; Bo H; Rosengren A; Kaur M; Mohan V; Lear SA; Teo KK; Leong D; O'Donnell M; McKee M; Dagenais G
    Lancet; 2020 Mar; 395(10226):795-808. PubMed ID: 31492503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of cardiovascular disease risk among low-income urban dwellers in metropolitan Kuala Lumpur, Malaysia.
    Su TT; Amiri M; Mohd Hairi F; Thangiah N; Bulgiba A; Majid HA
    Biomed Res Int; 2015; 2015():516984. PubMed ID: 25821810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular health among the Czech population at the beginning of the 21st century: a 12-year follow-up study.
    Lustigova M; Dzurova D; Pikhart H; Kubinova R; Bobak M
    J Epidemiol Community Health; 2018 May; 72(5):442-448. PubMed ID: 29439193
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.